Consequences of Shigella infection in young children: a systematic review
- PMID: 36736579
- PMCID: PMC10017352
- DOI: 10.1016/j.ijid.2023.01.034
Consequences of Shigella infection in young children: a systematic review
Abstract
Objectives: We conducted a systematic review of the longitudinal consequences of Shigella infection in children to inform the value proposition for an effective vaccine.
Methods: We searched PubMed and Embase for studies published from January 01, 1980 to December 12, 2022 and conducted in low- and middle-income countries that included longitudinal follow-up after Shigella detection among children aged <5 years, irrespective of language. We collected data on all outcomes subsequent to Shigella detection, except mortality.
Results: Of 2627 papers identified, 52 met inclusion criteria. The median sample size of children aged <5 years was 66 (range 5-2172). Data were collected in 20 countries; 56% (n = 29) of the publications included Bangladesh. The most common outcomes related to diarrhea (n = 20), linear growth (n = 14), and the mean total cost of a Shigella episode (n = 4; range: $ 6.22-31.10). Among children with Shigella diarrhea, 2.9-61.1% developed persistent diarrhea (≥14 days); the persistence was significantly more likely among children who were malnourished, had bloody stool, or had multidrug-resistant Shigella. Cumulative Shigella infections over the first 2 years of life contributed to the greatest loss in length-for-age z-score.
Conclusion: We identified evidence that Shigella is associated with persistent diarrhea, linear growth faltering, and economic impact to the family.
Keywords: Diarrhea; Enteric; Growth faltering; Shigella; Stunting; Vaccine.
Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.
Conflict of interest statement
Declaration of interests The authors have no competing interests to declare.
Figures
References
-
- Anderson JD, 4th, Bagamian KH, Muhib F, Amaya MP, Laytner LA, Wierzba T, et al. Burden of enterotoxigenic Escherichia coli and Shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: a modelling analysis. Lancet Glob Health. 2019;7:e321–e330. doi: 10.1016/S2214-109X(18)30483-2. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
